Biotech Values

[ghmm]

Would you have speakers at your own Investor Day roundtable that you knew didn't buy into the company line?

Not quite that scenario but I found it mildly bullish when BMRN acquired RNA they had a doctor on the call who was involved with both drisapersen and eteplirsen. He obviously didn't speak much about eteplirsen but made a passing positive remark or two about the drug. That BMRN would get someone involved with both rather than just some to profess the virtues of drisapersen spoke positively to what important people in DMD drugs thought.

For anyone interested the joing BMRN / PTCT MD Day investor event from the 22nd has a webcast replay now available. The links are:
Slides: http://files.shareholder.com/downloads/PTCT/334321829x0x836302/7DA38D13-28CC-4C56-8905-3AB6258984F4/PTCT_BMRN_June_22_DMD_Day_FINAL_updated.pdf

Webcast: http://edge.media-server.com/m/p/h8pmtpmg